整合临床参数、瘤周及栖息地放射组学的多模态预测模型用于术前鉴别滤泡性甲状腺癌与腺瘤:一项双中心研究
这项回顾性双中心研究纳入775例病理证实的滤泡性甲状腺肿瘤患者,构建整合临床参数、免疫标志物、瘤周放射组学及栖息地特征的多模态模型用于术前鉴别滤泡性甲状腺癌与腺瘤。整合模型在训练集、内部验证集和外部验证集的AUC分别为0.950、0.918和0.924,显著优于K-TIRADS(AUC分别为0.639、0.648和0.612)。
要点
- 多模态整合模型术前鉴别滤泡性甲状腺癌与腺瘤的AUC在外部验证集达0.924,优于K-TIRADS的0.612。
- 瘤周3mm梯度提升机模型AUC在训练集、内部验证集和外部验证集分别为0.881、0.865和0.868。
- 多因素分析确定甲状腺球蛋白、实性构成、低回声及淋巴细胞与单核细胞比值为独立预测因子。
核心结论
- 整合临床、瘤周及栖息地特征的多模态预测模型对术前鉴别滤泡性甲状腺癌表现出优秀性能,显著超越传统TIRADS系统,可增强临床决策支持。
研究设计与样本
- 回顾性双中心研究,纳入775例病理证实的滤泡性甲状腺肿瘤患者(训练集353例、内部验证集151例、外部验证集271例),从瘤内区域、瘤周扩展(1mm、3mm、5mm)及K-means聚类识别的栖息地亚区提取放射组学特征,评估逻辑回归、支持向量机、随机森林和梯度提升机四种机器学习算法。
诊断标准与关键数值
- 多因素分析识别四个独立预测因子:甲状腺球蛋白、实性构成、低回声及淋巴细胞与单核细胞比值;Peri-3mm梯度提升机模型AUC在训练集、内部验证集和外部验证集分别为0.881、0.865和0.868;联合栖息地梯度提升机模型AUC分别为0.900、0.852和0.860;整合临床预测因子与Peri-3mm及栖息地放射组学的整合模型AUC分别为0.950、0.918和0.924;K-TIRADS的AUC分别为0.639、0.648和0.612。
临床应用与阅片要点
- 作者认为整合临床、瘤周及栖息地特征的多模态预测模型可提供增强的临床决策支持;决策曲线分析证实整合模型在所有阈值概率下具有更优临床效用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Preoperative differentiation of follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA) remains challenging. This study aimed to develop and validate a multimodal prediction model integrating clinical parameters, immunological markers, peritumoral radiomics, and habitat-based features for accurate preoperative FTC diagnosis.
MATERIALS AND METHODS: This retrospective two-center study included 775 patients with pathologically confirmed follicular thyroid neoplasms (training set: n = 353; internal validation: n = 151; external validation: n = 271). Radiomics features were extracted from intratumoral regions, peritumoral extensions (1 mm, 3 mm, 5 mm), and habitat subregions identified through K-means clustering. Four machine learning algorithms (logistic regression, support vector machine, random forest, gradient boosting machine) were evaluated. Multivariate logistic regression identified independent clinical and immunological predictors. An integrated model combining optimal radiomics signatures with clinical predictors was constructed and compared with six established thyroid imaging reporting and data systems (TIRADS). Model interpretability was enhanced through SHAP analysis and nomogram visualization.
RESULTS: Multivariate analysis identified four independent predictors: thyroglobulin (TG), solid composition, hypoechoic echogenicity, and lymphocyte-to-monocyte ratio (LMR). The Peri-3mm gradient boosting machine (GBM) model achieved area under the curves (AUCs) of 0.881, 0.865, and 0.868 across cohorts. The combined Habitat GBM model demonstrated AUCs of 0.900, 0.852, and 0.860. The integrated model incorporating clinical predictors with Peri-3mm and Habitat radiomics achieved superior performance with AUCs of 0.950, 0.918, and 0.924 in training, internal validation, and external validation sets, respectively, substantially outperforming K-TIRADS (AUCs: 0.639, 0.648, 0.612). Decision curve analysis confirmed superior clinical utility of the integrated model across all threshold probabilities.
CONCLUSION: The multimodal prediction model integrating clinical, peritumoral, and habitat-based features demonstrates excellent performance for preoperative FTC differentiation, significantly surpassing conventional TIRADS systems and offering enhanced clinical decision-making support.
引用
- Liu SQ, Wang MX, Li H, et al. Multimodal Prediction Model Integrating Clinical Parameters, Peritumoral and Habitat-Based Radiomics for Preoperative Differentiation of Follicular Thyroid Carcinoma from Adenoma: A Two-Center Study. Acad Radiol. 2025. PMID: 41290428. doi:10.1016/j.acra.2025.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。